February 2014 Life Science Industry Research Reports

PharmaPoint: Ulcerative Colitis – Current and Future Players

Published in Feb 2014 ; US $ 2995 Onwards; Publisher: GlobalData

PharmaPoint: Ulcerative Colitis – Current and Future Players Summary GlobalData has released its pharma report, “PharmaPoint: Ulcerative Colitis – Current and Future Players”. The report is a vital source of up-to-date information with in-depth analysis on the companies in the […]

EVP-6124 (Schizophrenia) – Forecast and Market Analysis to 2022

Published in Feb 2014 ; US $ 3495 Onwards; Publisher: GlobalData

Schizophrenia is a persistent long-term brain disorder that causes severe, debilitating psychotic episodes. Its core symptoms, auditory or visual hallucinations, are often accompanied by fixed, false, and often paranoid beliefs, called delusions. These two features are often combined with learning […]

Bitopertin (Schizophrenia) – Forecast and Market Analysis to 2022

Published in Feb 2014 ; US $ 3495 Onwards; Publisher: GlobalData

Schizophrenia is a persistent long-term brain disorder that causes severe, debilitating psychotic episodes. Its core symptoms, auditory or visual hallucinations, are often accompanied by fixed, false, and often paranoid beliefs, called delusions. These two features are often combined with learning […]